Study of AVZO-021 in Patients With Advanced Solid Tumors

Clinical trial NCT05867251 · RECRUITING

Trial details

NCT number: NCT05867251
Sponsor: Avenzo Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor HR+/HER2- Breast Cancer HR+, HER2-, Advanced Breast Cancer CCNE1 Amplification Epithelial Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Endometrial Cancer TNBC - Triple-Negative Breast Cancer

Start date: 2023-08-30
Primary completion: 2028-01-31
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.